Oct 4, 2020 12:17 PM ET
iCrowd Newswire – Oct 4, 2020
With the presence of a large pool of participants, the global urinalysis market is displaying a highly competitive business landscape, finds a new research report by Zion Market Research (ZMR). Roche Diagnostics, ACON Laboratories Inc., Alere Inc., Teco Diagnostics, Olympus Corp., Fujifilm Holding Corp., Mindray, Siemens Healthcare, and Bio-Rad laboratories are some of the key vendors of urinalysis across the world. These players are focusing aggressively on innovation, as well as on including advanced technologies in their existing products. Over the coming years, they are also expected to take up partnerships and mergers and acquisitions as their key strategy for business development, states the urinalysis market study.
In a major boost to urinalysis market, U.S. FDA has provided a Class II approval to Smartphone- enabled urinalysis kit Dip.io manufactured by Healthy.io. As per the company sources, users can test their urine through Smartphone at home and share the data with their healthcare service provider.
Get Free Sample Of Report – https://www.zionmarketresearch.com/sample/urinalysis-market
Rise in Elderly Population Prone To Chronic Ailments To Spur Market Growth
“Growing cases of kidney disorders, diabetes, urinary tract infection, high blood pressure, and liver problems witnessed among the patient population base across the globe will drag the growth graph of urinalysis market in upward direction,” says the author of this study. Apart from this, rising geriatric population coupled with launching of technologically advanced diagnostics systems is forecast to further fuel the urinalysis market demand in the near future.
Strict government rules and poor healthcare infrastructure facility witnessed in developing countries, however, can hinder the urinalysis market development over the next few years. Nevertheless, unmet medical requirements observed in the developed economies and humungous target population base will generate lucrative opportunities for the urinalysis industry, normalizing the impact of hindrances on the business, reports the urinalysis market study.
Strong Presence Of Pharma Firms to Help North America Maintain Dominance
Regionally, North America has been leading the worldwide urinalysis market and is anticipated to continue on the dominant position in the years to come, states the urinalysis market study. The presence of a well-established pharmaceutical sector is the main factor behind the dominance of the North America urinalysis market. Furthermore, the burgeoning occurrence of chronic ailments along with increase in the levels of patient awareness will steer the urinalysis market expansion in the region.
The global urinalysis market is segmented as follows:
- Kidney Diseases
- Urinary Tract Infection
- Liver Diseases
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
To view TOC of this report – https://www.zionmarketresearch.com/toc/urinalysis-market
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: [email protected]
Keywords: Gobal Urinalysis Market